Literature DB >> 5058360

Current patterns of infection in multiple myeloma.

B R Meyers, S Z Hirschman, J A Axelrod.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5058360     DOI： 10.1016/0002-9343(72)90010-1

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  11 in total

1.  The effect of an IgM plasmacytoma (TEPC-183) on the primary immune response of BALB/c mice.

Authors:  H F Havas; G Schiffman
Journal:  Immunology       Date:  1978-01       Impact factor: 7.397

2.  Neisseria meningitidis serogroup 29E (Z') septicemia in a patient with far advanced multiple myeloma (plasma cell leukemia).

Authors:  E Wachter; A E Brown; T E Kiehn; B J Lee; D Armstrong
Journal:  J Clin Microbiol       Date:  1985-03       Impact factor: 5.948

3.  T-cell imbalances in patients with multiple myeloma: an analysis by monoclonal antibodies.

Authors:  C D Platsoucas; H J Hansen; J R Redman; S Berenson; B J Lee; B D Clarkson
Journal:  J Clin Immunol       Date:  1983-07       Impact factor: 8.317

4.  Protracted necrotizing pharyngitis associated with an acquired defect of neutrophil chemotaxis in multiple myeloma.

Authors:  K Bergsman; G Khatib; R Khatib; K Szwajkun
Journal:  Infection       Date:  1989 Nov-Dec       Impact factor: 3.553

5.  Cholecystitis associated with myelomatosis.

Authors:  D Sherlock; B Jones
Journal:  Postgrad Med J       Date:  1984-07       Impact factor: 2.401

Review 6.  Antibacterial therapy in patients with malignancies.

Authors:  K H Mayer; S M Opal
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

7.  Fungal infections in cancer patients: an international autopsy survey.

Authors:  G Bodey; B Bueltmann; W Duguid; D Gibbs; H Hanak; M Hotchi; G Mall; P Martino; F Meunier; S Milliken
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-02       Impact factor: 3.267

8.  Immunological factors and risk of infection in plateau phase myeloma.

Authors:  R M Hargreaves; J R Lea; H Griffiths; J A Faux; J M Holt; C Reid; C Bunch; M Lee; H M Chapel
Journal:  J Clin Pathol       Date:  1995-03       Impact factor: 3.411

Review 9.  Current guidelines on the use of antibacterial drugs in patients with malignancies.

Authors:  K H Mayer; O H DeTorres
Journal:  Drugs       Date:  1985-03       Impact factor: 9.546

10.  Serum antibodies against common antigens of bacterial lipopolysaccharides in healthy adults and in patients with multiple myeloma.

Authors:  C Stoll; I Schedel; D Peest
Journal:  Infection       Date:  1985 May-Jun       Impact factor: 3.553
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.